Better regulations initiative
This page describes a transhumanist political initiative that is supported by Transpolitica.
The initiative is summarised as A 21st century regulatory framework.
Description of initiative
The so-called “precautionary principle” preferred by some risk-averse policy makers is often self-defeating: seeking to avoid all risks can itself pose many risks. The precautionary principle frequently hinders intelligent innovation. The “proactionary principle” is a better stance, in which risks are assessed and managed in a balanced way, rather than always avoided. Any bias in favour of the status quo should be challenged, with an eye on better futures that can be created.
Transpolitica observes that many potentially revolutionary therapies are under research, but current drug development has become increasingly slow and expensive (as summarised by “Eroom’s law”). Translational research is doing badly, in part due to current drug regulations which are increasingly out of step with public opinion, actual usage, and technology.
In practical terms, Transpolitica recommends:
- Streamlining regulatory approval for new medicines, in line with recommendations by e.g. CASMI in the UK
- Removing any arbitrary legal distinction between “therapies for ill-health” and “therapies for enhancement”.
Transpolitica also urges revisions in patent and copyright laws to discourage counter-productive hoarding of intellectual property:
- Reduce the time periods of validity of patents in certain industry areas
- Make it much less likely that companies can be granted “obvious” patents that give them a throat-choke on subsequent development in an industry area
- Explore the feasibility of alternative and complementary schemes for facilitating open innovation, such as reputation economies or prize funds.